Built from live FDA enforcement data analysis
⏰ QMSR deadline: Feb 2, 2027 — Are you ready?
Trusted by 500+ medical device companies

Combination Products Regulatory Toolkit: FDA PMOA and cGMP Templates

Combination Products Toolkit — PMOA determination, regulatory strategy memo, drug-device design controls integration, constituent part agreement, cGMP compliance checklist, and RFD package template.

$2776+$347

Save 88% vs hiring a consultant

A consultant would charge $2,776+ for this documentation. Get it instantly for $347.

🛡️

7-Day Iron-Clad Guarantee

Download everything. Review every template. If it doesn't save you at least 40 hours of documentation work, email us for a full refund. No questions. No hassle.

Every week without proper documentation is another week of audit exposure.

The Audit-Ready Guarantee:7-day full refund if not 100% satisfied
500+
Device companies
87
Toolkits sold
4.9/5
Customer rating
💡

Save more with the Complete Suite

98 toolkits × $247 avg = $3,705+ value → Get everything for just $997

Save ${Math.max(0, product.price * 15 - 997)} — View Bundle →

What's Inside

6 templates, SOPs, and checklists
ready to customize
Built from analysis
of real FDA 483 observations
Average implementation: 2–3 days
(vs. 4–6 weeks with a consultant)
Combination Product Classification and PMOA Determination Template
Combination Product Regulatory Strategy Memo
Drug-Device Design Controls Integration Template
Combination Product Constituent Part Agreement Template
cGMP Compliance Checklist (21 CFR Part 4)
Request for Designation (RFD) Package Template
FREE BONUSES

Plus You'll Get These Bonuses Free

$47 Value

FDA Inspection Readiness Checklist

27-point checklist based on real 483 observations

$97/year Value

Quarterly Regulatory Updates

Free updates when FDA guidance changes

$29 Value

Implementation Quick-Start Guide

Step-by-step instructions to deploy templates in your QMS

Total Bonus Value: $173+ — Yours FREE with purchase

Benefits

PMOA determination framework with lead center routing logic
21 CFR Part 4 cGMP checklist avoids full dual-compliance burden
RFD package template reduces OCP clarification requests
Constituent part agreement covers FDA and EU MDR obligations between co-development parties

What QA/RA Professionals Say

Join 500+ medical device companies using RegWatchDaily templates

These templates saved us months of work. We passed our FDA inspection on the first try.

Sarah M.
QA Director, Class II Orthopedic Company
50-person manufacturer

Finally, templates that actually reflect how FDA inspectors think. Worth every penny.

Michael T.
RA Manager, Contract Manufacturer
ISO 13485 certified

We've used consultant templates before. These are better — more practical, less fluff.

Jennifer L.
VP Quality, Startup
Series A medical device company

Is This For You?

This toolkit is designed for teams facing these challenges:

PMOA unclear causing submission to be routed to wrong FDA center
cGMP compliance unclear for drug-device combination under 21 CFR Part 4
No quality agreement covering cross-constituent testing and change notification
RFD package incomplete causing OCP review delay

Who This Is For

RA leads managing drug-device combination product programsRegulatory consultants supporting combination product submissions to OCPProduct development teams building prefilled syringe or drug-delivery device productsCompanies developing drug-eluting devices requiring PMOA determination

The Audit-Ready Guarantee

Try the toolkit for 7 full days. If you don't feel more confident about your next FDA inspection, email us and we'll refund every penny — no questions asked. You keep the templates.

Your investment is 100% protected.

Frequently Asked Questions

What makes a product a combination product?

A product comprised of two or more regulated components (drug, device, biological) that are combined, co-packaged, or cross-labeled for co-use. Drug-eluting stents, prefilled syringes, and drug-delivery pens are common examples.

What does PMOA determine?

Primary Mode of Action determines which FDA center leads review: device PMOA routes to CDRH, drug PMOA to CDER, biological PMOA to CBER. This drives submission type, cGMP requirements, and regulatory strategy.

What file format are the templates in?

All templates are provided in editable Microsoft Word (.docx) format. You can customize them to match your company's branding and specific requirements.

How quickly will I receive the files?

Instantly. After purchase, you'll receive an email with download links within 2-3 minutes. Check your spam folder if you don't see it.

Can I use these for multiple projects or clients?

Yes. Your purchase includes a company-wide license. Use the templates across all your projects and devices within your organization.

Do these templates get updated when regulations change?

Yes. You'll receive free updates via email whenever we update templates for new guidance or regulatory changes.

What if I need help customizing the templates?

Email us at support@regwatchdaily.com. We typically respond within 24 hours with guidance on customization.

Is there a money-back guarantee?

Yes — the Audit-Ready Guarantee. If you're not satisfied within 7 days, email us for a full refund. No questions asked.

Ready to Get Audit-Ready?

Combination Products$347
+ FDA Inspection Readiness Checklist$47
+ Quarterly Regulatory Updates$97/year
+ Implementation Quick-Start Guide$29
Total Value$520+
Your Price Today$347
🛡️

7-Day Iron-Clad Guarantee

Download everything. Review every template. If it doesn't save you at least 40 hours of documentation work, email us for a full refund. No questions. No hassle.

Get Instant Access — $347

Every week without proper documentation is another week of audit exposure.

Secure checkoutInstant download7-day guarantee
Not quite ready? See smaller options →